T80.319A ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter

Name of the Condition

• ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter.

Summary

This condition describes an adverse immune reaction resulting from the transfusion of blood or blood products with incompatible ABO antigens, leading to hemolysis (destruction of red blood cells). It is a serious complication that can cause systemic effects, including organ damage and hemodynamic instability. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells. The "unspecified" designation indicates the reaction type is not further classified, and "initial encounter" denotes the first episode of care for this condition.

Causes

ABO incompatibility reactions result from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained during transfusion.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Nausea or vomiting
• Chest or abdominal pain
• Jaundice (yellowing of skin or eyes)

Diagnosis

Diagnosis involves clinical assessment of symptoms following transfusion, laboratory tests to detect hemolysis (e.g., elevated bilirubin, decreased haptoglobin, increased lactate dehydrogenase), and confirmation of ABO incompatibility through blood typing and crossmatching. Urinalysis may show hemoglobin or hemosiderin casts, and direct antiglobulin testing (Coombs test) can identify antibody-coated red blood cells. Imaging or additional tests may be used to evaluate organ involvement.

Treatment Options

Treatment focuses on stopping the transfusion immediately, maintaining hemodynamic stability with fluids or vasopressors, and managing symptoms (e.g., antipyretics for fever, analgesics for pain). Severe cases may require supportive care for organ dysfunction, such as renal replacement therapy for acute kidney injury or mechanical ventilation for respiratory failure. Corticosteroids or other immunosuppressants may be used in select cases, and transfusion of compatible blood products is avoided until the reaction resolves.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to life-threatening complications. Follow-up includes monitoring for delayed hemolysis, organ function recovery, and repeat blood typing to ensure future transfusion safety. Long-term care may involve evaluation for underlying conditions that increase transfusion risk.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multiorgan failure
• Pulmonary edema or acute respiratory distress syndrome (ARDS)
• Neurologic complications (e.g., stroke, seizures)
• Death (in severe cases)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing and crossmatching protocols before transfusion. Patients should inform healthcare providers of any prior transfusion reactions. For individuals with known antibodies, specialized blood products (e.g., washed red blood cells) may be used. Emergency protocols should minimize delays in typing to reduce risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or changes in urine color, during or after a blood transfusion. Prompt evaluation is critical to prevent severe complications.

Tips for Medical Coders

Document the type of transfusion reaction (hemolytic), the ABO incompatibility, and the encounter status (initial). Ensure clinical notes specify the reaction as "unspecified" if not further classified (e.g., acute or delayed). Code T80.319A is appropriate for the initial encounter of an unspecified hemolytic transfusion reaction due to ABO incompatibility. Verify that the transfusion context and reaction details support the code assignment.